Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells

被引:2
作者
Mahmoudinasab, Hamideh [1 ]
Saadat, Mostafa [1 ]
机构
[1] Shiraz Univ, Dept Biol, Coll Sci, Shiraz 7146713565, Iran
关键词
cisplatin; morphine; electromagnetic field; antioxidant genes; HZ MAGNETIC-FIELDS; ANTIOXIDANT GENES; OXIDATIVE STRESS; GENOMIC INSTABILITY; CANCER-CELLS; GLUTATHIONE; EXPOSURE;
D O I
10.1089/dna.2017.4108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin [cis-dichlorodiammine platinum (II), CDDP], morphine (Mor), and electromagnetic field (EMF) induced oxidative stress. In this study, we tried to increase the cytotoxicity of CDDP in combination with Mor and/or EMF in MCF-7 and SH-SY5Y cells. Furthermore, we evaluate the expression levels of 11 antioxidant genes in both cell lines. We designed four treatments: CDDP alone, CDDP+Mor, CDDP+EMF, and CDDP+Mor+EMF. Serial dilutions of CDDP, Mor (5.0M), and EMF (50Hz, 0.50 mT, 15min field-on/15min field-off) were used for estimation of relative IC50 values. The mRNA expression levels of antioxidant genes were determined by real-time PCR. The IC50 value of CDDP in CDDP+Mor+EMF treatment was significantly higher than CDDP alone and CDDP+Mor treatments in both cell lines. Whereas the expression levels of antioxidant genes in the four treatments showed similar patterns in MCF-7 cells, in SH-SY5Y cells, most of the antioxidant genes showed an upregulation with CDDP+EMF and CDDP+Mor+EMF treatments. Moreover, significant differences in the number of upregulated genes were observed between different treatments in SH-SY5Y cells. The molecular mechanism of CDDP-reduced cytotoxicity in our designed combinations is probably different in MCF-7 and SH-SY5Y cells. CDDP in combination with EMF could protect SH-SY5Y cells from the cytotoxicity, whereas it has no significant change in MCF-7 cells.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 31 条
[1]   Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation [J].
Baharara, Javad ;
Hosseini, Nasrin ;
Farzin, Tayebe Ramezani .
CYTOTECHNOLOGY, 2016, 68 (04) :1403-1413
[2]  
Boulikas T, 2003, ONCOL REP, V10, P1663
[3]   The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin [J].
Brozovic, Anamaria ;
Ambriovic-Ristov, Andreja ;
Osmak, Maja .
CRITICAL REVIEWS IN TOXICOLOGY, 2010, 40 (04) :347-359
[4]   Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells [J].
Buldak, Rafal Jakub ;
Polaniak, Renata ;
Buldak, Lukasz ;
Zwirska-Korczala, Krystyna ;
Skonieczna, Magdalena ;
Monsiol, Aleksandra ;
Kukla, Michal ;
Dulawa-Buldak, Anna ;
Birkner, Ewa .
BIOELECTROMAGNETICS, 2012, 33 (08) :641-651
[5]   Extremely Low-Frequency Magnetic Field Enhances the Therapeutic Efficacy of Low-Dose Cisplatin in the Treatment of Ehrlich Carcinoma [J].
El-Bialy, Nihal S. ;
Rageh, Monira M. .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[6]   Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms [J].
Falone, S. ;
Santini, S., Jr. ;
Cordone, V. ;
Cesare, P. ;
Bonfigli, A. ;
Grannonico, M. ;
Di Emidio, G. ;
Tatone, C. ;
Cacchio, M. ;
Amicarelli, F. .
SCIENTIFIC REPORTS, 2017, 7
[7]   The Use of Morphine to Treat Cancer-Related Pain: A Synthesis of Quantitative and Qualitative Research [J].
Flemming, Kate .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (01) :139-154
[8]  
Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351
[9]   Modulation of oxidative stress as an anticancer strategy [J].
Gorrini, Chiara ;
Harris, Isaac S. ;
Mak, Tak W. .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (12) :931-947
[10]   Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy [J].
Gupta, Subash C. ;
Hevia, David ;
Patchva, Sridevi ;
Park, Byoungduck ;
Koh, Wonil ;
Aggarwal, Bharat B. .
ANTIOXIDANTS & REDOX SIGNALING, 2012, 16 (11) :1295-1322